PETA submits comments to the EPA using existing data to address the test orders for 12 of the Phase I chemicals.
In a presentation at the 2010 Society of Toxicology meeting, PETA applies the OSRI in an integrated strategy to address data requirements for five of the Phase I chemicals.
The first meeting of the newly reorganized OECD Advisory Group on Testing and Assessment (EDTA-AG) is held in Paris, France, in March. The EDTA-AG is responsible for completing the endocrine assessment guidance document.
PETA is invited to present validation strategies for non-animal methods pertaining to assessment of endocrine activity at the Workshop on 21st Century Validation for 21st Century Tools presented by the Center for Alternatives to Animal Testing at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland, in July.
At the 2010 European Society for Toxicology In Vitro and European Society for Alternatives to Animal Testing Joint Congress, PETA presents a detailed integrated strategy for risk assessment for two Phase I chemicals.